Peptides have emerged as indispensable tools in modern drug discovery, playing a central role in areas such as oncology, metabolic disorders, targeted delivery, and protein–protein interaction ...
Timely access to high-quality peptides is essential in drug discovery, especially for screening, structure-activity relationship (SAR) studies, and early-stage preclinical research. Any delay in ...
“Following two very successful projects, we are excited to enter a third collaboration that combines the strengths of both companies.” said Dr. Sjoerd Wadman, Head of Chemistry at Novacta Therapeutics ...
The o2h Group has announced the first Cambridge x London Life Sciences Showcase, which will take place in San Francisco on 13 ...
Life science companies from Cambridge and London are off to San Francisco in the New Year to showcase their biotechnology ...
Digital technologies are permeating throughout pharma’s internal processes, and AstraZeneca has teamed up with DeepMatter to apply a digital approach to early-stage drug discovery. AZ has become the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback